159 related articles for article (PubMed ID: 15300196)
21. IGF-binding proteins mediate TGF-beta 1-induced apoptosis in bovine mammary epithelial BME-UV1 cells.
Gajewska M; Motyl T
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):65-75. PubMed ID: 15556067
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET.
Lynch MJ; Pelosi L; Carboni JM; Merwin J; Coleman K; Wang RC; Lin PF; Henry DL; Brattain MG
Cancer Res; 1993 Sep; 53(17):4041-7. PubMed ID: 8358733
[TBL] [Abstract][Full Text] [Related]
23. Effects of RNAi-mediated Smad4 silencing on growth and apoptosis of human rhabdomyosarcoma cells.
Ye L; Zhang H; Zhang L; Yang G; Ke Q; Guo H; Bu H
Int J Oncol; 2006 Nov; 29(5):1149-57. PubMed ID: 17016646
[TBL] [Abstract][Full Text] [Related]
24. Balance of pro-apoptotic transforming growth factor-beta and anti-apoptotic insulin effects in the control of cell death in the postnatal mouse retina.
Duenker N; Valenciano AI; Franke A; Hernández-Sánchez C; Dressel R; Behrendt M; De Pablo F; Krieglstein K; de la Rosa EJ
Eur J Neurosci; 2005 Jul; 22(1):28-38. PubMed ID: 16029193
[TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
[TBL] [Abstract][Full Text] [Related]
26. Runx3 controls growth and differentiation of gastric epithelial cells in mammals.
Fukamachi H
Dev Growth Differ; 2006 Jan; 48(1):1-13. PubMed ID: 16466388
[TBL] [Abstract][Full Text] [Related]
27. Density-dependent induction of apoptosis by transforming growth factor-beta 1 in a human ovarian carcinoma cell line.
Mathieu C; Jozan S; Mazars P; Côme MG; Moisand A; Valette A
Exp Cell Res; 1995 Jan; 216(1):13-20. PubMed ID: 7813613
[TBL] [Abstract][Full Text] [Related]
28. ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells.
Noda D; Itoh S; Watanabe Y; Inamitsu M; Dennler S; Itoh F; Koike S; Danielpour D; ten Dijke P; Kato M
Oncogene; 2006 Sep; 25(41):5591-600. PubMed ID: 16636667
[TBL] [Abstract][Full Text] [Related]
29. Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta.
Havrilesky LJ; Hurteau JA; Whitaker RS; Elbendary A; Wu S; Rodriguez GC; Bast RC; Berchuck A
Cancer Res; 1995 Feb; 55(4):944-8. PubMed ID: 7531618
[TBL] [Abstract][Full Text] [Related]
30. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
Raju U; Ariga H; Koto M; Lu X; Pickett J; Valdecanas D; Mason KA; Milas L
Radiother Oncol; 2006 Aug; 80(2):185-91. PubMed ID: 16905211
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
Heegaard AM; Xie Z; Young MF; Nielsen KL
J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625
[TBL] [Abstract][Full Text] [Related]
32. Induction of apoptosis by transforming growth factor beta 1 in glioma and trigeminal neurinoma cells.
Marushige K; Marushige Y
Anticancer Res; 1994; 14(6B):2419-24. PubMed ID: 7872662
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-beta is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33.
Kim AH; Lebman DA; Dietz CM; Snyder SR; Eley KW; Chung TD
Int J Oncol; 2003 Dec; 23(6):1593-9. PubMed ID: 14612931
[TBL] [Abstract][Full Text] [Related]
34. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
[TBL] [Abstract][Full Text] [Related]
35. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.
Wang P; Chen Z; Meng ZQ; Fan J; Luo JM; Liang W; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Xu ZD; Liu LM
Carcinogenesis; 2009 Sep; 30(9):1497-506. PubMed ID: 19546161
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor beta 1 induces apoptotic cell death in cultured human gastric carcinoma cells.
Yanagihara K; Tsumuraya M
Cancer Res; 1992 Jul; 52(14):4042-5. PubMed ID: 1319836
[TBL] [Abstract][Full Text] [Related]
37. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer.
Hsu PI; Hsieh HL; Lee J; Lin LF; Chen HC; Lu PJ; Hsiao M
Ann Surg Oncol; 2009 Jun; 16(6):1686-94. PubMed ID: 19290488
[TBL] [Abstract][Full Text] [Related]
38. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
39. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP.
Cui Q; Lim SK; Zhao B; Hoffmann FM
Oncogene; 2005 Jun; 24(24):3864-74. PubMed ID: 15750622
[TBL] [Abstract][Full Text] [Related]
40. Runt-related transcription factor 3 expression in human oral squamous cell carcinomas; implication for tumor progression and prognosis.
Tanji Y; Osaki M; Nagahama Y; Kodani I; Ryoke K; Ito H
Oral Oncol; 2007 Jan; 43(1):88-94. PubMed ID: 16798064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
